CTSOVSGTBP• 3 Months (Normalized)
CTSO vs GTBP (Cytosorbents Corporation vs GT Biopharma Inc.)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+1185.34%
Cytosorbents Corporation
Normalized Baseline0.00%
GTBP Performance $7.1
+1513.64%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-328.3 pts
GTBP outperforming by 328.30 percentage points
CTSOGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(59 dates)
| Date | CTSO Price | CTSO Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $4.91 | +1185.34% | $7.10 | +1513.64% | -328.30% |
| Sep 21, 2026 | $5.51 | +1342.41% | $7.18 | +1531.82% | -189.41% |
| Sep 18, 2026 | $5.75 | +1405.24% | $7.16 | +1527.27% | -122.03% |
| Sep 17, 2026 | $5.76 | +1407.85% | $7.49 | +1602.27% | -194.42% |
| Sep 16, 2026 | $5.73 | +1400.00% | $7.81 | +1675.00% | -275.00% |
| Sep 15, 2026 | $6.06 | +1486.39% | $9.00 | +1945.45% | -459.06% |
| Sep 14, 2026 | $6.07 | +1489.01% | $11.63 | +2543.18% | -1054.17% |
| Sep 11, 2026 | $6.41 | +1578.01% | $8.61 | +1856.82% | -278.81% |
| Sep 10, 2026 | $6.37 | +1567.54% | $6.18 | +1304.55% | +262.99% |
| Sep 09, 2026 | $6.33 | +1557.07% | $5.98 | +1259.09% | +297.98% |
| Sep 04, 2026 | $0.35 | -8.38% | $0.24 | -45.23% | +36.85% |
| Sep 03, 2026 | $0.35 | -8.38% | $0.25 | -42.73% | +34.35% |
| Sep 02, 2026 | $0.38 | +0.52% | $0.28 | -35.68% | +36.20% |
| Sep 01, 2026 | $0.34 | -11.52% | $0.29 | -34.32% | +22.80% |
| Aug 31, 2026 | $0.34 | -10.73% | $0.29 | -35.00% | +24.27% |
Page 1 of 4